Turun biotiedekeskus
Yhteystiedot
Henkilöt
Julkaisut
- CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations (2015)
- CIP2A is a critical DNA damage response protein that drives basal-like breast cancer (2023)
- CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance (2015)
- CIP2A-promoted astrogliosis induces AD-like synaptic degeneration and cognitive deficits (2019)
- CIP2A Promotes T-Cell Activation and Immune Response to Listeria monocytogenes Infection (2016)
- Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children (2023)
- Circulating metabolites in progression to islet autoimmunity and type 1 diabetes (2019)
- Circulating Triacylglycerol Signatures in Nonalcoholic Fatty Liver Disease Associated With the I148M Variant in PNPLA3 and With Obesity (2014)
- Circumventing drug treatment? Intrinsic lethal effects of polyethyleneimine (PEI)-functionalized nanoparticles on glioblastoma cells cultured in stem cell conditions (2021)
- Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma (2022)